Answers are grounded in this paper and cite their sources.
) that can cause clinical features when homozygous or co-inherited with other hemoglobinopathies. Regional data on Hb D-Punjab in the Kurdistan Region of Iraq remain limited. This study evaluated the frequency, clinical features, and molecular and laboratory profiles of Hb D-Punjab cases in the Kurdistan Region of Iraq (KRI). The cohort included 3,200 consecutive patients whose samples were referred for hemoglobinopathy screening between February 2023 and February 2026 to a tertiary referral laboratory in Sulaymaniyah, Iraq. All samples were analyzed using high-performance liquid chromatography (HPLC; Bio-Rad D-10). Variant peaks at a retention time of 3.91 minutes (D-window) on HPLC were also confirmed by capillary zone electrophoresis. In addition, all cases were validated by targeted Next-Generation Sequencing (NGS) of the HBB gene. Hb D-Punjab was detected in 12 patients, yielding a frequency of 0.38% (12/3,200), including 9 females and 3 males, aged 9-47 years. Eleven patients (91.7%) had the heterozygous Hb D-Punjab trait (Hb AD-Punjab). All were asymptomatic (mean Hb 12.27 ± 2.13 g/dL, MCV 78.00 ± 9.77 fL). One 28-year-old male patient had homozygous Hb D-Punjab, presenting with moderate microcytic anemia (Hb 9.6 g/dL, MCV 56.6 fL, MCH 19.2 pg), mild icterus, target cells, and 56.8% Hb D-Punjab. Hb D-Punjab has a low prevalence (0.38%) in the KRI. The trait is clinically silent, whereas homozygous Hb D-Punjab presents with moderate microcytic hypochromic anemia. Combining HPLC retention times with secondary capillary electrophoresis and NGS enables accurate diagnosis and prevents misclassification.
No takes yet. Share an insight, caveat, or question.
Getta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: